节点文献

溶栓和抗凝方案治疗肺栓塞疗效分析

Thrombolytic Therapy versus Anticoagulant Therapy for Pulmonary Embolism:Evaluation of Therapeutic Efficacy

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 马成花

【Author】 MA Cheng-hua(Qinghai Provincial People’s Hospital,Xining 810007,China)

【机构】 青海省人民医院药剂科

【摘要】 目的:尿激酶溶栓方案和低分子肝素抗凝方案治疗肺栓塞疗效的评价。方法:收集41名肺栓塞患者治疗资料,回顾性分析溶栓治疗和抗凝治疗的疗效,比较两组患者呼吸困难、胸痛等症状缓解率以及血气指标改善情况等。结果:与抗凝治疗组相比,溶栓治疗组患者呼吸困难、胸痛、咳嗽、咳血和紫绀缓解率均高于抗凝治疗组(P<0.1),治疗有效率高于抗凝治疗组(P<0.05)。结论:依本次实验结果可认为尿激酶溶栓治疗疗效优于低分子肝素抗凝治疗。

【Abstract】 OBJECTIVE:To evaluate the clinical efficacy of thrombolytic therapy with Urokinase versus anticoagulant therapy with Low Molecular Heparin in the treatment of pulmonary embolism.METHODS:The clinical records of 41 patients with pulmonary embolism were collected and the efficacy of thrombolytic therapy versus anticoagulant therapy in dyspnea and chest pain and the blood gas indexes were analyzed retrospectively.RESULTS:Compared with the anticoagulant therapy group,the remission rates of dyspnea,chest pain,cough,hemoptisis and cyanosis were all significantly higher(P<0.1)and the effective rate was also higher(P<0.05)in the thrombolytic therapy group.CONCLUSION:The results suggest that the therapeutic efficacy of thrombolytic therapy with Urokinase is higher than that of anticoagulant therapy with Low Molecular Heparin in the treatment of pulmonary embolism.

  • 【文献出处】 中国医院用药评价与分析 ,Evaluation and Analysis of Drug-Use in Hospitals of China , 编辑部邮箱 ,2008年10期
  • 【分类号】R563.5
  • 【被引频次】9
  • 【下载频次】153
节点文献中: 

本文链接的文献网络图示:

本文的引文网络